TAMSULOSIN-TEVA PROLONGED RELEASE FILM-COATED TABLET 400MCG

Ország: Szingapúr

Nyelv: angol

Forrás: HSA (Health Sciences Authority)

Aktív összetevők:

Tamsulosin eqv Tamsulosin hydrochloride

Beszerezhető a:

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

ATC-kód:

G04CA02

Gyógyszerészeti forma:

TABLET, FILM COATED, EXTENDED RELEASE

Összetétel:

Tamsulosin eqv Tamsulosin hydrochloride 0.40 mg

Az alkalmazás módja:

ORAL

Recept típusa:

Prescription Only

Gyártó:

Teva Pharmaceutical Works Private Limited Company

Engedélyezési státusz:

ACTIVE

Engedély dátuma:

2021-05-11

Termékjellemzők

TAMSULOSIN-TEVA PROLONGED RELEASE FILM-COATED TABLET 400MCG
ACTIVE SUBSTANCE
Tamsulosin hydrochloride
DESCRIPTION
Tamsulosin-Teva is a film-coated, prolonged release tablet containing
400 mcg
tamsulosin hydrochloride, an α1-adrenoceptor blocking agent. It has a
high affinity
for the α1A- receptor subtype predominantly present in the human
prostate. The
chemical structure of tamsulosin hydrochloride is:
The chemical name is
(R)-5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-
methoxybenzenesulfonamide, monohydrochloride. The molecular weight is
444.98.
The CAS registry number is CAS-106463-17-6 (hydrochloride).
Tamsulosin-Teva also contains cellulose microcrystalline, polyethylene
oxide, colloidal
anhydrous silica, magnesium stearate, hypromellose, titanium dioxide,
macrogol 8000,
iron oxide yellow, iron oxide red. None of the excipients is derived
from animal sources.
Tamsulosin hydrochloride is sparingly soluble in water (1:85) and
slightly soluble in
alcohol. It is stable in an acid environment.
PHARMACOLOGY
The tone of the human prostate smooth muscle is maintained primarily
by noradrenaline
released from adrenergic nerves and stimulating post-junctional
α1-adrenoceptors. This
provides the rationale for the use of α1-adrenoceptor antagonists for
lower urinary tract
symptoms associated with benign prostatic hyperplasia (BPH).
PHARMACODYNAMICS
Pharmacological studies have established that tamsulosin is a
selective, potent and
competitive α1-adrenoceptor antagonist and that it has a greater
affinity for the α1A-
receptor subtype, predominantly present in the human prostate.
α1-adrenoceptor antagonists generally can reduce blood pressure by
lowering peripheral
resistance. However, no reduction in blood pressure of any clinical
significance was
observed during studies with Tamsulosin.
The binding of tamsulosin to α1-adrenoceptors in the prostate results
in relaxation of
prostate smooth muscle followed by improvements in urodynamics. Thus,
Tamsulosin
increases maximum urinary flow rate by reducing smooth mus